The Global Curcumin Market size is expected to reach $219.4 Million by 2030, rising at a market growth of 14.9% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,768.6 Tonnes, experiencing a growth of 14.8% (2019-2022).
Many individuals incorporate curcumin into their diets or supplement regimens to proactively support their health and reduce the risk of chronic diseases. Consequently, the pharmaceutical segment captured $36.9 Million revenue in the market in 2022. Consumer consciousness about the benefits of curcumin for joint health and pain management has driven demand for curcumin supplements among individuals looking for natural alternatives to over-the-counter pain relief. Curcumin’s potential to support digestive health and alleviate symptoms of conditions like irritable bowel syndrome has made it popular among individuals with gastrointestinal concerns. Its use in skincare products is influenced by consumer awareness of its potential to improve skin health, reduce signs of aging, and address skin conditions like acne and psoriasis. The rise in consumer consciousness regarding the health benefits of curcumin has been a pivotal factor in driving the growth of the market. Some of the factors impacting the market are expansion of clinical utility of curcumin extract, rising chronic health conditions and adulteration and fraudulent products.
Clinical evidence establishes credibility for curcumin, making it more attractive to consumers who seek science-backed products. This trust encourages consumers to incorporate curcumin-containing products into their daily routines, further boosting market growth. Healthcare professionals are increasingly recommending curcumin supplements or curcumin-rich foods to their patients. As curcumin becomes a more mainstream and trusted option for health support, its market growth is reinforced. Clinical research has highlighted its potential in managing joint pain and inflammation. The prevalence of chronic health conditions, including inflammatory diseases, cancer, and neurodegenerative disorders, has spurred interest in potential natural therapies. Its potent anti-inflammatory properties have led to its adoption as a natural remedy for managing inflammation, a common feature of many chronic illnesses. Arthritis, a common chronic condition, involves joint inflammation and pain. To support joint health and lessen arthritic symptoms like stiffness and soreness, curcumin is frequently used as a dietary supplement. Some individuals use curcumin to alleviate symptoms and reduce inflammation in rheumatoid arthritis and lupus. As a result of the rising chronic health conditions, the market is anticipated to increase significantly.
However, the market has seen instances of adulteration and fraudulent products. Some suppliers mix curcumin with other substances to reduce costs, leading to product authenticity and quality concerns. Adulterants or fraudulent substances in curcumin products can pose safety risks. Consumers unknowingly consume harmful or allergenic ingredients, resulting in adverse health effects and potential legal issues for manufacturers. Fraudulent products with unproven health claims can discredit the legitimate market. Negative experiences with such products can lead consumers to question the actual health benefits of curcumin. Legitimate curcumin manufacturers and suppliers can suffer reputational damage if their products are falsely associated with adulterated or fraudulent versions. Building and maintaining brand trust becomes challenging. Adulteration and fraudulent products are significant challenges that hamper the market.
Nature Outlook
Based on nature, the market is classified into organic and conventional. The organic segment acquired a substantial revenue share in the market in 2022. Organic curcumin, sourced from organic turmeric, aligns with this demand for transparency and clean labeling. The absence of synthetic pesticides, herbicides, and chemical fertilizers in cultivating organic turmeric appeals to health-conscious consumers. The organic nature of curcumin resonates with the broader health and wellness trend. Organic farming procedures prohibit the use of synthetic chemicals. As a result, organic curcumin is less likely to contain synthetic pesticides and fertilizer residues.
Application Outlook
By application, the market is categorized into pharmaceutical, food, cosmetics, and others. In 2022, the pharmaceutical segment held the highest revenue share in the market. It is a powerful antioxidant that neutralizes harmful free radicals in the body. Curcumin’s antioxidant properties make it an attractive option for developing pharmaceuticals to reduce oxidative damage and promote overall health. Curcumin has been investigated for its potential in managing neurodegenerative disorders, such as Alzheimer’s disease and Parkinson’s disease. Curcumin’s anti-inflammatory and antimicrobial properties make it a candidate for pharmaceuticals related to wound healing and the treatment of skin disorders.
Regional Outlook
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. North America has a growing interest in alternative medicine and integrative health practices. North America has seen a significant shift towards health and wellness, with consumers actively seeking products that support their well-being. The pharmaceutical industry in North America has invested in research on curcumin’s potential therapeutic properties. The diversity of North American cuisine and the popularity of ethnic foods have led to the increased use of curcumin in spice blends and seasonings.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Wacker Chemie AG, Hindustan Mint & Agro Products Pvt. Ltd, Arjuna Natural Extracts Ltd, Synthite Industries Ltd., SV Agrofood, Star Hi Herbs Pvt. Ltd., Herboveda India Pvt. Ltd., Konark Herbals & Healthcare, Sabinsa corporation and The Green Lab LLC.
Scope of the Study
Market Segments covered in the Report:
By Nature (Volume, Tonnes, USD Million, 2019-30)

  • Conventional
  • Organic

By Application (Volume, Tonnes, USD Million, 2019-30)

  • Pharmaceutical
  • Food
  • Cosmetics
  • Others

By Geography (Volume, Tonnes, USD Million, 2019-30)

  • North America

o US
o Canada
o Mexico
o Rest of North America

  • Europe

o Germany
o UK
o France
o Russia
o Spain
o Italy
o Rest of Europe

  • Asia Pacific

o China
o Japan
o India
o South Korea
o Singapore
o Malaysia
o Rest of Asia Pacific


o Brazil
o Argentina
o Saudi Arabia
o South Africa
o Nigeria
o Rest of LAMEA
Companies Profiled

  • Wacker Chemie AG
  • Hindustan Mint & Agro Products Pvt. Ltd
  • Arjuna Natural Extracts Ltd
  • Synthite Industries Ltd.
  • SV Agrofood
  • Star Hi Herbs Pvt. Ltd.
  • Herboveda India Pvt. Ltd.
  • Konark Herbals & Healthcare
  • Sabinsa corporation
  • The Green Lab LLC

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free